Their data showed that TFE3 break-apart FISH assay was a useful complementary method for confirming the diagnosis of Xp11 translocation RCC, especially when the morphologic or clinical suspicion was high but TFE3 immunostaining was negative or equivocal. This evidence concerns the gene TFE3 and renal cell carcinoma.